Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06016764 · ClinicalTrials.gov registry record · Phase 1
Use of MRI and cTBS for Catatonia in Autism
A Phase 1 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT06016764 is a Phase 1 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 26 participants.
The verdict
NCT06016764, a Phase 1 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
Despite the significant morbidity and mortality associated with catatonia in autism, no diagnostic research has attempted to identify biomarkers for catatonia. This application will use a participant's own individual brain magnetic resonance image to target the primary motor strip with transcranial magnetic stimulation; to determine if hyper-excitability of the brain directly correlates with symptoms of catatonia and social-emotional impairment in autism. Completion of this project would result in the first study to associate hyper-excitability of the brain with catatonia and core features of autism; findings which are likely to have a significant impact on the health and well-being of autistic individuals.
Interventions
- DEVICE Continuous Theta Burst in Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-08-23 |
| Est. Completion | 2025-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06016764
The ClinicalTrials.gov registry entry for NCT06016764 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Theta Burst in Transcranial Magnetic Stimulation is the first listed.
NCT06016764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06016764 about?
NCT06016764 is a clinical study titled "Use of MRI and cTBS for Catatonia in Autism". Despite the significant morbidity and mortality associated with catatonia in autism, no diagnostic research has attempted to identify biomarkers for catatonia. This application will use a participant's own individual brain magnetic resonance image to target the primary motor strip with transcranial ...
What is the current status of trial NCT06016764?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2023-08-23. Estimated completion is 2025-12-01.
What interventions are being tested in trial NCT06016764?
The interventions under investigation include: Continuous Theta Burst in Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06016764?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.